BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Rare Collective - ECPv6.7.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://rarecollective.org
X-WR-CALDESC:Events for Rare Collective
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20160101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160929
DTEND;VALUE=DATE:20161001
DTSTAMP:20260420T125251
CREATED:20160906T183659Z
LAST-MODIFIED:20160908T171416Z
UID:76-1475107200-1475279999@rarecollective.org
SUMMARY:Rare Disease Market Access and Orphan Drug Commercialization
DESCRIPTION:Join market access and commercialization executives from pharmaceutical and biotech companies with a focus on rare\, genetic\, and orphan diseases to explore the current commercial dynamics surrounding these unique products. This Summit evaluates market forces\, their economic impact\, and the implications for orphan drug market access – covering early stage commercialization efforts through pricing\, reimbursement\, and patient and market access considerations. \nTop Reasons to Attend: \n\nLearn strategies to enhance your patient-centered approach to product commercialization\nDiscuss lessons learned between industry and advocacy partnerships\nUnderstand key pricing models and how to develop a cost effectiveness model for your product\nGain insight from payers on how they manage orphan drug pricing and reimbursement and their perceptions on value in relation to price\nDive into the mechanics of lobbying in the rare disease space\nDetermine how to choose the right distribution model for market success
URL:https://rarecollective.org/event/rare-disease-market-access-and-orphan-drug-commercialization/
LOCATION:Hyatt Regency Boston\, 1 Ave de Lafayette\, Boston\, MA\, 02111\, United States
CATEGORIES:Attending
END:VEVENT
END:VCALENDAR